Evidence map›Paper›PMID 27170638›Full record

ArticleAmerican journal of physiology. Cell physiology2016

NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx.

Michael A Katsnelson, Kristen M Lozada-Soto, Hana M Russo, Barbara A Miller, George R Dubyak

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael A KatsnelsonDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio;
Kristen M Lozada-SotoDepartment of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio;
Hana M RussoDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio;
Barbara A MillerDepartment of Pediatrics, Penn State Hershey Children's Hospital, Hershey, Pennsylvania.
George R DubyakDepartment of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio; george.dubyak@case.edu.
Case Western Reserve University · USPenn State Milton S. Hershey Medical Center · USUniversity School · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Toll Like Receptors in Bacterial KeratitisR01EY014362 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI GEORGE R DUBYAK, Eric Pearlman · 2003 to 2026
$8.7M
Postbaccalaureate Research Education ProgramR25GM075207 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI CRAWFORD, DANA C · 2006 to 2024
$5.6M
TRANSMEMBRANE SIGNALLING IN SMOOTH MUSCLE CELL LINESR01GM036387 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI DUBYAK, GEORGE R · 1987 to 2014
$4.5M
Immunology Training Program-PredoctoralT32AI089474 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI COBB, BRIAN A · 2010 to 2025
$3.4M
Cardiovascular Research Training Program (CRTP)T32HL105338 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI JAIN, MUKESH KUMAR · 2010 to 2014
$1.8M
NEI NIH HHS R01 EY014362NHLBI NIH HHS T32 HL105338NIAID NIH HHS T32 AI089474NIGMS NIH HHS R01 GM036387NIGMS NIH HHS R25 GM075207NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Nucleotide-binding domain, leucine-rich-repeat-containing family, pyrin domain-containing 3 (NLRP3) is a cytosolic protein that nucleates assembly of inflammasome signaling platforms, which facilitate caspase-1-mediated IL-1β release and other inflammatory responses in myeloid leukocytes. NLRP3 inflammasomes are assembled in response to multiple pathogen- or environmental stress-induced changes in basic cell physiology, including the destabilization of lysosome integrity and activation of K(+)-permeable channels/transporters in the plasma membrane (PM). However, the quantitative relationships between lysosome membrane permeabilization (LMP), induction of increased PM K(+) permeability, and activation of NLRP3 signaling are incompletely characterized. We used Leu-Leu-O-methyl ester (LLME), a soluble lysosomotropic agent, to quantitatively track the kinetics and extent of LMP in relation to NLRP3 inflammasome signaling responses (ASC oligomerization, caspase-1 activation, IL-1β release) and PM cation fluxes in murine bone marrow-derived dendritic cells (BMDCs). Treatment of BMDCs with submillimolar (≤1 mM) LLME induced slower and partial increases in LMP that correlated with robust NLRP3 inflammasome activation and K(+) efflux. In contrast, supramillimolar (≥2 mM) LLME elicited extremely rapid and complete collapse of lysosome integrity that was correlated with suppression of inflammasome signaling. Supramillimolar LLME also induced dominant negative effects on inflammasome activation by the canonical NLRP3 agonist nigericin; this inhibition correlated with an increase in NLRP3 ubiquitination. LMP elicited rapid BMDC death by both inflammasome-dependent pyroptosis and inflammasome-independent necrosis. LMP also triggered Ca(2+) influx, which attenuated LLME-stimulated NLRP3 inflammasome signaling but potentiated LLME-induced necrosis. Taken together, these studies reveal a previously unappreciated signaling network that defines the coupling between LMP, changes in PM cation fluxes, cell death, and NLRP3 inflammasome activation.

Indexed as

Calcium SignalingAnimalsApoptosis Regulatory ProteinsCalciumCARD Signaling Adaptor ProteinsCaspase 1CaspasesCaspases, InitiatorCells, CulturedDendritic CellsDipeptidesDose-Response Relationship, DrugInflammasomesInterleukin-1betaKineticsLysosomesApoptosis Regulatory ProteinsCalciumCARD Signaling Adaptor ProteinsCasp4 protein, mouseCaspase 1CaspasesCaspases, InitiatorDipeptidesIL1B protein, mouseInflammasomesInterleukin-1betaleucyl-leucine-methyl esterNigericinNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePotassiumPycard protein, mouseTRPM2 protein, mouseTRPM Cation Channelscaspase-1cell deathdendritic cellIL-1ion channels

Identifiers

PMID27170638
PMCPMC4967136
OpenAlexW2392032823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.